Previous 10 | Next 10 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its inaugural environmental social and governance (ESG) report highlighting Twist’s approach to susta...
Don't think that the current malaise for biotech investors will last forever. There are some biotech stocks that have tremendous long-term potential. We asked three Motley Fool contributors to identify biotech stocks they think could deliver 5x returns by 2030. Here's why they chose C...
CRISPR Therapeutics (NASDAQ: CRSP) focuses on modifying DNA. Twist Bioscience (NASDAQ: TWST) focuses on making DNA. Both companies' technologies appear to have tremendous potential. But which is the better biotech stock to buy? That's the question that Motley Fool contributo...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Artisan Development Labs Inc. (DBA Artisan Bio), an immune cell engineering company developing next-generation cell the...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 first quarter ended December 31, 2021, before ...
The beating that life science stocks have taken lately is enough to make most investors think twice before risking another hard-earned dollar in this topsy-turvey corner of the stock market. If you can detach your emotions from your math skills, though, you know that there's no better time ...
-- Reveals Plug and Play, Low Cost, No Scar, Scalable Enzymatic Synthesis 3.0 -- -- Partners with PacBio, Singular Genomics Enabling New Sequencing Platforms -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering ...
- Twist launches expert-designed panel that facilitates canine genomic research in partnership with Broad Institute Vertebrate Genomics Group – - Canine research could benefit research into several human diseases, including cancer – Twist Bioscience Corporation...
-- Results independently confirmed through live virus plaque-reduction assay -- -- Results published on BioRxiv and submitted to the FDA as part of pre-IND data package -- Revelar Biotherapeutics, Inc. and Twist Bioscience Corporation (Nasdaq: TWST) t...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 40th Annual J.P....
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...